CHRM1 and schizophrenia: Hence, as it is increasingly recognized the molecular pathology of diseases of the human CNS extend into the periphery (Scarr et al., 2015; Lai et al., 2016b), it will be important to consider if CHRM1-mediated pathophysiology in disorders such as schizophrenia also extends beyond the CNS.